APO Research
Talk to an analyst

APO RESEARCH · REPORT

Therapeutic Nuclear Medicines

Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.

Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.

Selected research

Market Analysis & Forecast

Global Therapeutic Nuclear Medicines Market Analysis and Forecast 2026-2032

21 December 2025196 pages

Choose your research edition.

Industry ResearchTherapeutic Nuclear Medicines Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Therapeutic Nuclear Medicines Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Therapeutic Nuclear Medicines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Therapeutic Nuclear Medicines Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Therapeutic Nuclear Medicines Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.

Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.

Global Therapeutic Nuclear Medicines key players include Bayer, Novartis AG, China Isotope & Radiation, etc. Global top three manufacturers hold a share over 75%.

Read the full market overview

North America is the largest market, with a share about 45%, followed by Europe and Asia-Pacific, both have a share about 50 percent.

In terms of product, Radium-223 is the largest segment, with a share over 45%. And in terms of application, the largest application is Thyroid, followed by Bone Metastasis.

This report presents an overview of global market for Therapeutic Nuclear Medicines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Therapeutic Nuclear Medicines, also provides the sales of main regions and countries. Of the upcoming market potential for Therapeutic Nuclear Medicines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Therapeutic Nuclear Medicines sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Therapeutic Nuclear Medicines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Therapeutic Nuclear Medicines sales, projected growth trends, production technology, application and end-user industry.

Therapeutic Nuclear Medicines Segment by Company

Novartis AG

Bayer

China Isotope & Radiation

Q BioMed

Curium Pharmaceuticals

Jubilant DraxImage

Dongcheng

Lantheus

Acrotech Biopharma.

Progenics Pharmaceuticals

International Isotopes

Therapeutic Nuclear Medicines Segment by Type

Radium-223

Lutetium-177

Iodine-131

Other

Therapeutic Nuclear Medicines Segment by Application

Thyroid

Bone Metastasis

Lymphoma

Other

Therapeutic Nuclear Medicines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Therapeutic Nuclear Medicines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Therapeutic Nuclear Medicines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Therapeutic Nuclear Medicines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Therapeutic Nuclear Medicines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Therapeutic Nuclear Medicines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Therapeutic Nuclear Medicines sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Therapeutic Nuclear Medicines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Radium-223 Major Manufacturers Table 3. Lutetium-177 Major Manufacturers Table 4. Iodine-131 Major Manufacturers Table 5. Other Major Manufacturers Table 6. Global Therapeutic Nuclear Medicines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Thyroid Major Manufacturers Table 8. Bone Metastasis Major Manufacturers Table 9. Lymphoma Major Manufacturers Table 10. Other Major Manufacturers Table 11. Therapeutic Nuclear Medicines Industry Trends Table 12. Therapeutic Nuclear Medicines Industry Drivers Table 13. Therapeutic Nuclear Medicines Industry Opportunities and Challenges Table 14. Therapeutic Nuclear Medicines Industry Restraints Table 15. Global Therapeutic Nuclear Medicines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Therapeutic Nuclear Medicines Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Therapeutic Nuclear Medicines Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Therapeutic Nuclear Medicines Revenue Market Share by Region (2021-2026) Table 19. Global Therapeutic Nuclear Medicines Revenue Market Share by Region (2027-2032) Table 20. Global Therapeutic Nuclear Medicines Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 21. Global Therapeutic Nuclear Medicines Sales by Region (2021-2026) & (k units) Table 22. Global Therapeutic Nuclear Medicines Sales by Region (2027-2032) & (k units) Table 23. Global Therapeutic Nuclear Medicines Sales Market Share by Region (2021-2026) Table 24. Global Therapeutic Nuclear Medicines Sales Market Share by Region (2027-2032) Table 25. Global Therapeutic Nuclear Medicines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Therapeutic Nuclear Medicines Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Therapeutic Nuclear Medicines Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Therapeutic Nuclear Medicines Sales Market Share by Manufacturers (2021-2026) Table 29. Global Therapeutic Nuclear Medicines Sales Price (USD/unit) of Manufacturers (2021-2026) Table 30. Global Therapeutic Nuclear Medicines Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Therapeutic Nuclear Medicines Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Therapeutic Nuclear Medicines Manufacturers, Product Type & Application Table 33. Global Therapeutic Nuclear Medicines Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Therapeutic Nuclear Medicines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Therapeutic Nuclear Medicines Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Therapeutic Nuclear Medicines Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Therapeutic Nuclear Medicines Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Therapeutic Nuclear Medicines Revenue Market Share by Type (2021-2026) Table 40. Global Therapeutic Nuclear Medicines Revenue Market Share by Type (2027-2032) Table 41. Global Therapeutic Nuclear Medicines Sales by Type 2021 VS 2025 VS 2032 (k units) Table 42. Global Therapeutic Nuclear Medicines Sales by Type (2021-2026) & (k units) Table 43. Global Therapeutic Nuclear Medicines Sales by Type (2027-2032) & (k units) Table 44. Global Therapeutic Nuclear Medicines Sales Market Share by Type (2021-2026) Table 45. Global Therapeutic Nuclear Medicines Sales Market Share by Type (2027-2032) Table 46. Global Therapeutic Nuclear Medicines Price by Type (2021-2026) & (USD/unit) Table 47. Global Therapeutic Nuclear Medicines Price by Type (2027-2032) & (USD/unit) Table 48. Global Therapeutic Nuclear Medicines Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Therapeutic Nuclear Medicines Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Therapeutic Nuclear Medicines Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Therapeutic Nuclear Medicines Revenue Market Share by Application (2021-2026) Table 52. Global Therapeutic Nuclear Medicines Revenue Market Share by Application (2027-2032) Table 53. Global Therapeutic Nuclear Medicines Sales by Application 2021 VS 2025 VS 2032 (k units) Table 54. Global Therapeutic Nuclear Medicines Sales by Application (2021-2026) & (k units) Table 55. Global Therapeutic Nuclear Medicines Sales by Application (2027-2032) & (k units) Table 56. Global Therapeutic Nuclear Medicines Sales Market Share by Application (2021-2026) Table 57. Global Therapeutic Nuclear Medicines Sales Market Share by Application (2027-2032) Table 58. Global Therapeutic Nuclear Medicines Price by Application (2021-2026) & (USD/unit) Table 59. Global Therapeutic Nuclear Medicines Price by Application (2027-2032) & (USD/unit) Table 60. Novartis AG Company Information Table 61. Novartis AG Business Overview Table 62. Novartis AG Therapeutic Nuclear Medicines Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 63. Novartis AG Therapeutic Nuclear Medicines Product Portfolio Table 64. Novartis AG Recent Development Table 65. Bayer Company Information Table 66. Bayer Business Overview Table 67. Bayer Therapeutic Nuclear Medicines Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 68. Bayer Therapeutic Nuclear Medicines Product Portfolio Table 69. Bayer Recent Development Table 70. China Isotope & Radiation Company Information Table 71. China Isotope & Radiation Business Overview Table 72. China Isotope & Radiation Therapeutic Nuclear Medicines Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 73. China Isotope & Radiation Therapeutic Nuclear Medicines Product Portfolio Table 74. China Isotope & Radiation Recent Development Table 75. Q BioMed Company Information Table 76. Q BioMed Business Overview Table 77. Q BioMed Therapeutic Nuclear Medicines Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 78. Q BioMed Therapeutic Nuclear Medicines Product Portfolio Table 79. Q BioMed Recent Development Table 80. Curium Pharmaceuticals Company Information Table 81. Curium Pharmaceuticals Business Overview Table 82. Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 83. Curium Pharmaceuticals Therapeutic Nuclear Medicines Product Portfolio Table 84. Curium Pharmaceuticals Recent Development Table 85. Jubilant DraxImage Company Information Table 86. Jubilant DraxImage Business Overview Table 87. Jubilant DraxImage Therapeutic Nuclear Medicines Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Jubilant DraxImage Therapeutic Nuclear Medicines Product Portfolio Table 89. Jubilant DraxImage Recent Development Table 90. Dongcheng Company Information Table 91. Dongcheng Business Overview Table 92. Dongcheng Therapeutic Nuclear Medicines Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Dongcheng Therapeutic Nuclear Medicines Product Portfolio Table 94. Dongcheng Recent Development Table 95. Lantheus Company Information Table 96. Lantheus Business Overview Table 97. Lantheus Therapeutic Nuclear Medicines Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Lantheus Therapeutic Nuclear Medicines Product Portfolio Table 99. Lantheus Recent Development Table 100. Acrotech Biopharma. Company Information Table 101. Acrotech Biopharma. Business Overview Table 102. Acrotech Biopharma. Therapeutic Nuclear Medicines Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Acrotech Biopharma. Therapeutic Nuclear Medicines Product Portfolio Table 104. Acrotech Biopharma. Recent Development Table 105. Progenics Pharmaceuticals Company Information Table 106. Progenics Pharmaceuticals Business Overview Table 107. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product Portfolio Table 109. Progenics Pharmaceuticals Recent Development Table 110. International Isotopes Company Information Table 111. International Isotopes Business Overview Table 112. International Isotopes Therapeutic Nuclear Medicines Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. International Isotopes Therapeutic Nuclear Medicines Product Portfolio Table 114. International Isotopes Recent Development Table 115. North America Therapeutic Nuclear Medicines Revenue by Type (2021-2026) & (US$ Million) Table 116. North America Therapeutic Nuclear Medicines Revenue by Type (2027-2032) & (US$ Million) Table 117. North America Therapeutic Nuclear Medicines Sales by Type (2021-2026) & (k units) Table 118. North America Therapeutic Nuclear Medicines Sales by Type (2027-2032) & (k units) Table 119. North America Therapeutic Nuclear Medicines Sales Price by Type (2021-2026) & (USD/unit) Table 120. North America Therapeutic Nuclear Medicines Sales Price by Type (2027-2032) & (USD/unit) Table 121. North America Therapeutic Nuclear Medicines Revenue by Application (2021-2026) & (US$ Million) Table 122. North America Therapeutic Nuclear Medicines Revenue by Application (2027-2032) & (US$ Million) Table 123. North America Therapeutic Nuclear Medicines Sales by Application (2021-2026) & (k units) Table 124. North America Therapeutic Nuclear Medicines Sales by Application (2027-2032) & (k units) Table 125. North America Therapeutic Nuclear Medicines Sales Price by Application (2021-2026) & (USD/unit) Table 126. North America Therapeutic Nuclear Medicines Sales Price by Application (2027-2032) & (USD/unit) Table 127. North America Therapeutic Nuclear Medicines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. North America Therapeutic Nuclear Medicines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 129. North America Therapeutic Nuclear Medicines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 130. North America Therapeutic Nuclear Medicines Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 131. North America Therapeutic Nuclear Medicines Sales by Country (2021-2026) & (k units) Table 132. North America Therapeutic Nuclear Medicines Sales by Country (2027-2032) & (k units) Table 133. North America Therapeutic Nuclear Medicines Sales Price by Country (2021-2026) & (USD/unit) Table 134. North America Therapeutic Nuclear Medicines Sales Price by Country (2027-2032) & (USD/unit) Table 135. United States Therapeutic Nuclear Medicines Revenue (2021-2032) & (US$ Million) Table 136. Canada Therapeutic Nuclear Medicines Revenue (2021-2032) & (US$ Million) Table 137. Mexico Therapeutic Nuclear Medicines Revenue (2021-2032) & (US$ Million) Table 138. Europe Therapeutic Nuclear Medicines Revenue by Type (2021-2026) & (US$ Million) Table 139. Europe Therapeutic Nuclear Medicines Revenue by Type (2027-2032) & (US$ Million) Table 140. Europe Therapeutic Nuclear Medicines Sales by Type (2021-2026) & (k units) Table 141. Europe Therapeutic Nuclear Medicines Sales by Type (2027-2032) & (k units) Table 142. Europe Therapeutic Nuclear Medicines Sales Price by Type (2021-2026) & (USD/unit) Table 143. Europe Therapeutic Nuclear Medicines Sales Price by Type (2027-2032) & (USD/unit) Table 144. Europe Therapeutic Nuclear Medicines Revenue by Application (2021-2026) & (US$ Million) Table 145. Europe Therapeutic Nuclear Medicines Revenue by Application (2027-2032) & (US$ Million) Table 146. Europe Therapeutic Nuclear Medicines Sales by Application (2021-2026) & (k units) Table 147. Europe Therapeutic Nuclear Medicines Sales by Application (2027-2032) & (k units) Table 148. Europe Therapeutic Nuclear Medicines Sales Price by Application (2021-2026) & (USD/unit) Table 149. Europe Therapeutic Nuclear Medicines Sales Price by Application (2027-2032) & (USD/unit) Table 150. Europe Therapeutic Nuclear Medicines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 151. Europe Therapeutic Nuclear Medicines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 152. Europe Therapeutic Nuclear Medicines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 153. Europe Therapeutic Nuclear Medicines Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 154. Europe Therapeutic Nuclear Medicines Sales by Country (2021-2026) & (k units) Table 155. Europe Therapeutic Nuclear Medicines Sales by Country (2027-2032) & (k units) Table 156. Europe Therapeutic Nuclear Medicines Sales Price by Country (2021-2026) & (USD/unit) Table 157. Europe Therapeutic Nuclear Medicines Sales Price by Country (2027-2032) & (USD/unit) Table 158. Germany Therapeutic Nuclear Medicines Revenue (2021-2032) & (US$ Million) Table 159. France Therapeutic Nuclear Medicines Revenue (2021-2032) & (US$ Million) Table 160. U.K. Therapeutic Nuclear Medicines Revenue (2021-2032) & (US$ Million) Table 161. Italy Therapeutic Nuclear Medicines Revenue (2021-2032) & (US$ Million) Table 162. Russia Therapeutic Nuclear Medicines Revenue (2021-2032) & (US$ Million) Table 163. Spain Therapeutic Nuclear Medicines Revenue (2021-2032) & (US$ Million) Table 164. Netherlands Therapeutic Nuclear Medicines Revenue (2021-2032) & (US$ Million) Table 165. Switzerland Therapeutic Nuclear Medicines Revenue (2021-2032) & (US$ Million) Table 166. Sweden Therapeutic Nuclear Medicines Revenue (2021-2032) & (US$ Million) Table 167. Poland Therapeutic Nuclear Medicines Revenue (2021-2032) & (US$ Million) Table 168. China Therapeutic Nuclear Medicines Revenue by Type (2021-2026) & (US$ Million) Table 169. China Therapeutic Nuclear Medicines Revenue by Type (2027-2032) & (US$ Million) Table 170. China Therapeutic Nuclear Medicines Sales by Type (2021-2026) & (k units) Table 171. China Therapeutic Nuclear Medicines Sales by Type (2027-2032) & (k units) Table 172. China Therapeutic Nuclear Medicines Sales Price by Type (2021-2026) & (USD/unit) Table 173. China Therapeutic Nuclear Medicines Sales Price by Type (2027-2032) & (USD/unit) Table 174. China Therapeutic Nuclear Medicines Revenue by Application (2021-2026) & (US$ Million) Table 175. China Therapeutic Nuclear Medicines Revenue by Application (2027-2032) & (US$ Million) Table 176. China Therapeutic Nuclear Medicines Sales by Application (2021-2026) & (k units) Table 177. China Therapeutic Nuclear Medicines Sales by Application (2027-2032) & (k units) Table 178. China Therapeutic Nuclear Medicines Sales Price by Application (2021-2026) & (USD/unit) Table 179. China Therapeutic Nuclear Medicines Sales Price by Application (2027-2032) & (USD/unit) Table 180. Asia Therapeutic Nuclear Medicines Revenue by Type (2021-2026) & (US$ Million) Table 181. Asia Therapeutic Nuclear Medicines Revenue by Type (2027-2032) & (US$ Million) Table 182. Asia Therapeutic Nuclear Medicines Sales by Type (2021-2026) & (k units) Table 183. Asia Therapeutic Nuclear Medicines Sales by Type (2027-2032) & (k units) Table 184. Asia Therapeutic Nuclear Medicines Sales Price by Type (2021-2026) & (USD/unit) Table 185. Asia Therapeutic Nuclear Medicines Sales Price by Type (2027-2032) & (USD/unit) Table 186. Asia Therapeutic Nuclear Medicines Revenue by Application (2021-2026) & (US$ Million) Table 187. Asia Therapeutic Nuclear Medicines Revenue by Application (2027-2032) & (US$ Million) Table 188. Asia Therapeutic Nuclear Medicines Sales by Application (2021-2026) & (k units) Table 189. Asia Therapeutic Nuclear Medicines Sales by Application (2027-2032) & (k units) Table 190. Asia Therapeutic Nuclear Medicines Sales Price by Application (2021-2026) & (USD/unit) Table 191. Asia Therapeutic Nuclear Medicines Sales Price by Application (2027-2032) & (USD/unit) Table 192. Asia Therapeutic Nuclear Medicines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 193. Asia Therapeutic Nuclear Medicines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 194. Asia Therapeutic Nuclear Medicines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 195. Asia Therapeutic Nuclear Medicines Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 196. Asia Therapeutic Nuclear Medicines Sales by Country (2021-2026) & (k units) Table 197. Asia Therapeutic Nuclear Medicines Sales by Country (2027-2032) & (k units) Table 198. Asia Therapeutic Nuclear Medicines Sales Price by Country (2021-2026) & (USD/unit) Table 199. Asia Therapeutic Nuclear Medicines Sales Price by Country (2027-2032) & (USD/unit) Table 200. Japan Therapeutic Nuclear Medicines Revenue (2021-2032) & (US$ Million) Table 201. South Korea Therapeutic Nuclear Medicines Revenue (2021-2032) & (US$ Million) Table 202. India Therapeutic Nuclear Medicines Revenue (2021-2032) & (US$ Million) Table 203. Australia Therapeutic Nuclear Medicines Revenue (2021-2032) & (US$ Million) Table 204. Taiwan Therapeutic Nuclear Medicines Revenue (2021-2032) & (US$ Million) Table 205. Southeast Asia Therapeutic Nuclear Medicines Revenue (2021-2032) & (US$ Million) Table 206. SAMEA Therapeutic Nuclear Medicines Revenue by Type (2021-2026) & (US$ Million) Table 207. SAMEA Therapeutic Nuclear Medicines Revenue by Type (2027-2032) & (US$ Million) Table 208. SAMEA Therapeutic Nuclear Medicines Sales by Type (2021-2026) & (k units) Table 209. SAMEA Therapeutic Nuclear Medicines Sales by Type (2027-2032) & (k units) Table 210. SAMEA Therapeutic Nuclear Medicines Sales Price by Type (2021-2026) & (USD/unit) Table 211. SAMEA Therapeutic Nuclear Medicines Sales Price by Type (2027-2032) & (USD/unit) Table 212. SAMEA Therapeutic Nuclear Medicines Revenue by Application (2021-2026) & (US$ Million) Table 213. SAMEA Therapeutic Nuclear Medicines Revenue by Application (2027-2032) & (US$ Million) Table 214. SAMEA Therapeutic Nuclear Medicines Sales by Application (2021-2026) & (k units) Table 215. SAMEA Therapeutic Nuclear Medicines Sales by Application (2027-2032) & (k units) Table 216. SAMEA Therapeutic Nuclear Medicines Sales Price by Application (2021-2026) & (USD/unit) Table 217. SAMEA Therapeutic Nuclear Medicines Sales Price by Application (2027-2032) & (USD/unit) Table 218. SAMEA Therapeutic Nuclear Medicines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 219. SAMEA Therapeutic Nuclear Medicines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 220. SAMEA Therapeutic Nuclear Medicines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 221. SAMEA Therapeutic Nuclear Medicines Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 222. SAMEA Therapeutic Nuclear Medicines Sales by Country (2021-2026) & (k units) Table 223. SAMEA Therapeutic Nuclear Medicines Sales by Country (2027-2032) & (k units) Table 224. SAMEA Therapeutic Nuclear Medicines Sales Price by Country (2021-2026) & (USD/unit) Table 225. SAMEA Therapeutic Nuclear Medicines Sales Price by Country (2027-2032) & (USD/unit) Table 226. Brazil Therapeutic Nuclear Medicines Revenue (2021-2032) & (US$ Million) Table 227. Argentina Therapeutic Nuclear Medicines Revenue (2021-2032) & (US$ Million) Table 228. Chile Therapeutic Nuclear Medicines Revenue (2021-2032) & (US$ Million) Table 229. Colombia Therapeutic Nuclear Medicines Revenue (2021-2032) & (US$ Million) Table 230. Peru Therapeutic Nuclear Medicines Revenue (2021-2032) & (US$ Million) Table 231. Saudi Arabia Therapeutic Nuclear Medicines Revenue (2021-2032) & (US$ Million) Table 232. Israel Therapeutic Nuclear Medicines Revenue (2021-2032) & (US$ Million) Table 233. UAE Therapeutic Nuclear Medicines Revenue (2021-2032) & (US$ Million) Table 234. Turkey Therapeutic Nuclear Medicines Revenue (2021-2032) & (US$ Million) Table 235. Iran Therapeutic Nuclear Medicines Revenue (2021-2032) & (US$ Million) Table 236. Egypt Therapeutic Nuclear Medicines Revenue (2021-2032) & (US$ Million) Table 237. Key Raw Materials Table 238. Raw Materials Key Suppliers Table 239. Therapeutic Nuclear Medicines Distributors List Table 240. Therapeutic Nuclear Medicines Customers List Table 241. Research Programs/Design for This Report Table 242. Authors List of This Report Table 243. Secondary Sources Table 244. Primary Sources List of Figures Figure 1. Therapeutic Nuclear Medicines Image Figure 2. Global Therapeutic Nuclear Medicines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Therapeutic Nuclear Medicines Market Size Share 2021 VS 2025 VS 2032 Figure 4. Radium-223 Image Figure 5. Lutetium-177 Image Figure 6. Iodine-131 Image Figure 7. Other Image Figure 8. Global Therapeutic Nuclear Medicines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Therapeutic Nuclear Medicines Market Size Share 2021 VS 2025 VS 2032 Figure 10. Thyroid Image Figure 11. Bone Metastasis Image Figure 12. Lymphoma Image Figure 13. Other Image Figure 14. Global Therapeutic Nuclear Medicines Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Therapeutic Nuclear Medicines Revenue (2021-2032) & (US$ Million) Figure 16. Global Therapeutic Nuclear Medicines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Therapeutic Nuclear Medicines Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Therapeutic Nuclear Medicines Revenue Market Share by Region (2021-2032) Figure 19. Global Therapeutic Nuclear Medicines Sales (2021-2032) & (k units) Figure 20. Global Therapeutic Nuclear Medicines Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 21. Global Therapeutic Nuclear Medicines Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Therapeutic Nuclear Medicines Sales YoY (2021-2032) & (k units) Figure 23. Europe Therapeutic Nuclear Medicines Sales YoY (2021-2032) & (k units) Figure 24. China Therapeutic Nuclear Medicines Sales YoY (2021-2032) & (k units) Figure 25. Asia (Excluding China) Therapeutic Nuclear Medicines Sales YoY (2021-2032) & (k units) Figure 26. South America, Middle East and Africa Therapeutic Nuclear Medicines Sales YoY (2021-2032) & (k units) Figure 27. Global Therapeutic Nuclear Medicines Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Therapeutic Nuclear Medicines Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Therapeutic Nuclear Medicines Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Therapeutic Nuclear Medicines Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Therapeutic Nuclear Medicines Revenue Market Share by Type (2021-2032) Figure 33. Global Therapeutic Nuclear Medicines Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 34. Global Therapeutic Nuclear Medicines Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Therapeutic Nuclear Medicines Sales Market Share by Type (2021-2032) Figure 36. Global Therapeutic Nuclear Medicines Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Therapeutic Nuclear Medicines Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Therapeutic Nuclear Medicines Revenue Market Share by Application (2021-2032) Figure 39. Global Therapeutic Nuclear Medicines Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 40. Global Therapeutic Nuclear Medicines Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Therapeutic Nuclear Medicines Sales Market Share by Application (2021-2032) Figure 42. North America Therapeutic Nuclear Medicines Revenue Share by Type (2021-2032) Figure 43. North America Therapeutic Nuclear Medicines Sales Share by Type (2021-2032) Figure 44. North America Therapeutic Nuclear Medicines Revenue Share by Application (2021-2032) Figure 45. North America Therapeutic Nuclear Medicines Sales Share by Application (2021-2032) Figure 46. North America Therapeutic Nuclear Medicines Revenue Share by Country (2021-2032) Figure 47. North America Therapeutic Nuclear Medicines Sales Share by Country (2021-2032) Figure 48. Europe Therapeutic Nuclear Medicines Revenue Share by Type (2021-2032) Figure 49. Europe Therapeutic Nuclear Medicines Sales Share by Type (2021-2032) Figure 50. Europe Therapeutic Nuclear Medicines Revenue Share by Application (2021-2032) Figure 51. Europe Therapeutic Nuclear Medicines Sales Share by Application (2021-2032) Figure 52. Europe Therapeutic Nuclear Medicines Revenue Share by Country (2021-2032) Figure 53. Europe Therapeutic Nuclear Medicines Sales Share by Country (2021-2032) Figure 54. China Therapeutic Nuclear Medicines Revenue Share by Type (2021-2032) Figure 55. China Therapeutic Nuclear Medicines Sales Share by Type (2021-2032) Figure 56. China Therapeutic Nuclear Medicines Revenue Share by Application (2021-2032) Figure 57. China Therapeutic Nuclear Medicines Sales Share by Application (2021-2032) Figure 58. Asia Therapeutic Nuclear Medicines Revenue Share by Type (2021-2032) Figure 59. Asia Therapeutic Nuclear Medicines Sales Share by Type (2021-2032) Figure 60. Asia Therapeutic Nuclear Medicines Revenue Share by Application (2021-2032) Figure 61. Asia Therapeutic Nuclear Medicines Sales Share by Application (2021-2032) Figure 62. Asia Therapeutic Nuclear Medicines Revenue Share by Country (2021-2032) Figure 63. Asia Therapeutic Nuclear Medicines Sales Share by Country (2021-2032) Figure 64. SAMEA Therapeutic Nuclear Medicines Revenue Share by Type (2021-2032) Figure 65. SAMEA Therapeutic Nuclear Medicines Sales Share by Type (2021-2032) Figure 66. SAMEA Therapeutic Nuclear Medicines Revenue Share by Application (2021-2032) Figure 67. SAMEA Therapeutic Nuclear Medicines Sales Share by Application (2021-2032) Figure 68. SAMEA Therapeutic Nuclear Medicines Revenue Share by Country (2021-2032) Figure 69. SAMEA Therapeutic Nuclear Medicines Sales Share by Country (2021-2032) Figure 70. Therapeutic Nuclear Medicines Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Therapeutic Nuclear Medicines Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Radium-223
  • Lutetium-177
  • Iodine-131
  • Other
Applications
  • Thyroid
  • Bone Metastasis
  • Lymphoma
  • Other
Companies covered
  • Novartis AG
  • Bayer
  • China Isotope & Radiation
  • Q BioMed
  • Curium Pharmaceuticals
  • Jubilant DraxImage
  • Dongcheng
  • Lantheus
  • Acrotech Biopharma.
  • Progenics Pharmaceuticals
  • International Isotopes

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Therapeutic Nuclear Medicines Market by Type
  3. 1.2.1 Global Therapeutic Nuclear Medicines Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Radium-223
  5. 1.2.3 Lutetium-177
  6. 1.2.4 Iodine-131
  7. 1.2.5 Other
  8. 1.3 Therapeutic Nuclear Medicines Market by Application
  9. 1.3.1 Global Therapeutic Nuclear Medicines Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Thyroid
  11. 1.3.3 Bone Metastasis
  12. 1.3.4 Lymphoma
  13. 1.3.5 Other
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Therapeutic Nuclear Medicines Market Dynamics
  1. 2.1 Therapeutic Nuclear Medicines Industry Trends
  2. 2.2 Therapeutic Nuclear Medicines Industry Drivers
  3. 2.3 Therapeutic Nuclear Medicines Industry Opportunities and Challenges
  4. 2.4 Therapeutic Nuclear Medicines Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Therapeutic Nuclear Medicines Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Therapeutic Nuclear Medicines Revenue by Region
  3. 3.2.1 Global Therapeutic Nuclear Medicines Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Therapeutic Nuclear Medicines Revenue by Region (2021-2026)
  5. 3.2.3 Global Therapeutic Nuclear Medicines Revenue by Region (2027-2032)
  6. 3.2.4 Global Therapeutic Nuclear Medicines Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Therapeutic Nuclear Medicines Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Therapeutic Nuclear Medicines Sales by Region
  9. 3.4.1 Global Therapeutic Nuclear Medicines Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Therapeutic Nuclear Medicines Sales by Region (2021-2026)
  11. 3.4.3 Global Therapeutic Nuclear Medicines Sales by Region (2027-2032)
  12. 3.4.4 Global Therapeutic Nuclear Medicines Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Therapeutic Nuclear Medicines Revenue by Manufacturers
  2. 4.1.1 Global Therapeutic Nuclear Medicines Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Therapeutic Nuclear Medicines Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Therapeutic Nuclear Medicines Sales by Manufacturers
  6. 4.2.1 Global Therapeutic Nuclear Medicines Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Therapeutic Nuclear Medicines Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Therapeutic Nuclear Medicines Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Therapeutic Nuclear Medicines Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Therapeutic Nuclear Medicines Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Therapeutic Nuclear Medicines Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Therapeutic Nuclear Medicines Manufacturers, Product Type & Application
  13. 4.7 Global Therapeutic Nuclear Medicines Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Therapeutic Nuclear Medicines Market CR5 and HHI
  16. 4.8.2 2025 Therapeutic Nuclear Medicines Tier 1, Tier 2, and Tier 3
5 Therapeutic Nuclear Medicines Market by Type
  1. 5.1 Global Therapeutic Nuclear Medicines Revenue by Type
  2. 5.1.1 Global Therapeutic Nuclear Medicines Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Therapeutic Nuclear Medicines Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Therapeutic Nuclear Medicines Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Therapeutic Nuclear Medicines Sales by Type
  6. 5.2.1 Global Therapeutic Nuclear Medicines Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Therapeutic Nuclear Medicines Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Therapeutic Nuclear Medicines Sales Market Share by Type (2021-2032)
  9. 5.3 Global Therapeutic Nuclear Medicines Price by Type
6 Therapeutic Nuclear Medicines Market by Application
  1. 6.1 Global Therapeutic Nuclear Medicines Revenue by Application
  2. 6.1.1 Global Therapeutic Nuclear Medicines Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Therapeutic Nuclear Medicines Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Therapeutic Nuclear Medicines Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Therapeutic Nuclear Medicines Sales by Application
  6. 6.2.1 Global Therapeutic Nuclear Medicines Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Therapeutic Nuclear Medicines Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Therapeutic Nuclear Medicines Sales Market Share by Application (2021-2032)
  9. 6.3 Global Therapeutic Nuclear Medicines Price by Application
7 Company Profiles
  1. 7.1 Novartis AG
  2. 7.1.1 Novartis AG Company Information
  3. 7.1.2 Novartis AG Business Overview
  4. 7.1.3 Novartis AG Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Novartis AG Therapeutic Nuclear Medicines Product Portfolio
  6. 7.1.5 Novartis AG Recent Developments
  7. 7.2 Bayer
  8. 7.2.1 Bayer Company Information
  9. 7.2.2 Bayer Business Overview
  10. 7.2.3 Bayer Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Bayer Therapeutic Nuclear Medicines Product Portfolio
  12. 7.2.5 Bayer Recent Developments
  13. 7.3 China Isotope & Radiation
  14. 7.3.1 China Isotope & Radiation Company Information
  15. 7.3.2 China Isotope & Radiation Business Overview
  16. 7.3.3 China Isotope & Radiation Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 China Isotope & Radiation Therapeutic Nuclear Medicines Product Portfolio
  18. 7.3.5 China Isotope & Radiation Recent Developments
  19. 7.4 Q BioMed
  20. 7.4.1 Q BioMed Company Information
  21. 7.4.2 Q BioMed Business Overview
  22. 7.4.3 Q BioMed Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Q BioMed Therapeutic Nuclear Medicines Product Portfolio
  24. 7.4.5 Q BioMed Recent Developments
  25. 7.5 Curium Pharmaceuticals
  26. 7.5.1 Curium Pharmaceuticals Company Information
  27. 7.5.2 Curium Pharmaceuticals Business Overview
  28. 7.5.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Curium Pharmaceuticals Therapeutic Nuclear Medicines Product Portfolio
  30. 7.5.5 Curium Pharmaceuticals Recent Developments
  31. 7.6 Jubilant DraxImage
  32. 7.6.1 Jubilant DraxImage Company Information
  33. 7.6.2 Jubilant DraxImage Business Overview
  34. 7.6.3 Jubilant DraxImage Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Jubilant DraxImage Therapeutic Nuclear Medicines Product Portfolio
  36. 7.6.5 Jubilant DraxImage Recent Developments
  37. 7.7 Dongcheng
  38. 7.7.1 Dongcheng Company Information
  39. 7.7.2 Dongcheng Business Overview
  40. 7.7.3 Dongcheng Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Dongcheng Therapeutic Nuclear Medicines Product Portfolio
  42. 7.7.5 Dongcheng Recent Developments
  43. 7.8 Lantheus
  44. 7.8.1 Lantheus Company Information
  45. 7.8.2 Lantheus Business Overview
  46. 7.8.3 Lantheus Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Lantheus Therapeutic Nuclear Medicines Product Portfolio
  48. 7.8.5 Lantheus Recent Developments
  49. 7.9 Acrotech Biopharma.
  50. 7.9.1 Acrotech Biopharma. Company Information
  51. 7.9.2 Acrotech Biopharma. Business Overview
  52. 7.9.3 Acrotech Biopharma. Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Acrotech Biopharma. Therapeutic Nuclear Medicines Product Portfolio
  54. 7.9.5 Acrotech Biopharma. Recent Developments
  55. 7.10 Progenics Pharmaceuticals
  56. 7.10.1 Progenics Pharmaceuticals Company Information
  57. 7.10.2 Progenics Pharmaceuticals Business Overview
  58. 7.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product Portfolio
  60. 7.10.5 Progenics Pharmaceuticals Recent Developments
  61. 7.11 International Isotopes
  62. 7.11.1 International Isotopes Company Information
  63. 7.11.2 International Isotopes Business Overview
  64. 7.11.3 International Isotopes Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 International Isotopes Therapeutic Nuclear Medicines Product Portfolio
  66. 7.11.5 International Isotopes Recent Developments
8 North America
  1. 8.1 North America Therapeutic Nuclear Medicines Market Size by Type
  2. 8.1.1 North America Therapeutic Nuclear Medicines Revenue by Type (2021-2032)
  3. 8.1.2 North America Therapeutic Nuclear Medicines Sales by Type (2021-2032)
  4. 8.1.3 North America Therapeutic Nuclear Medicines Price by Type (2021-2032)
  5. 8.2 North America Therapeutic Nuclear Medicines Market Size by Application
  6. 8.2.1 North America Therapeutic Nuclear Medicines Revenue by Application (2021-2032)
  7. 8.2.2 North America Therapeutic Nuclear Medicines Sales by Application (2021-2032)
  8. 8.2.3 North America Therapeutic Nuclear Medicines Price by Application (2021-2032)
  9. 8.3 North America Therapeutic Nuclear Medicines Market Size by Country
  10. 8.3.1 North America Therapeutic Nuclear Medicines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Therapeutic Nuclear Medicines Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Therapeutic Nuclear Medicines Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Therapeutic Nuclear Medicines Market Size by Type
  2. 9.1.1 Europe Therapeutic Nuclear Medicines Revenue by Type (2021-2032)
  3. 9.1.2 Europe Therapeutic Nuclear Medicines Sales by Type (2021-2032)
  4. 9.1.3 Europe Therapeutic Nuclear Medicines Price by Type (2021-2032)
  5. 9.2 Europe Therapeutic Nuclear Medicines Market Size by Application
  6. 9.2.1 Europe Therapeutic Nuclear Medicines Revenue by Application (2021-2032)
  7. 9.2.2 Europe Therapeutic Nuclear Medicines Sales by Application (2021-2032)
  8. 9.2.3 Europe Therapeutic Nuclear Medicines Price by Application (2021-2032)
  9. 9.3 Europe Therapeutic Nuclear Medicines Market Size by Country
  10. 9.3.1 Europe Therapeutic Nuclear Medicines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Therapeutic Nuclear Medicines Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Therapeutic Nuclear Medicines Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Therapeutic Nuclear Medicines Market Size by Type
  2. 10.1.1 China Therapeutic Nuclear Medicines Revenue by Type (2021-2032)
  3. 10.1.2 China Therapeutic Nuclear Medicines Sales by Type (2021-2032)
  4. 10.1.3 China Therapeutic Nuclear Medicines Price by Type (2021-2032)
  5. 10.2 China Therapeutic Nuclear Medicines Market Size by Application
  6. 10.2.1 China Therapeutic Nuclear Medicines Revenue by Application (2021-2032)
  7. 10.2.2 China Therapeutic Nuclear Medicines Sales by Application (2021-2032)
  8. 10.2.3 China Therapeutic Nuclear Medicines Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Therapeutic Nuclear Medicines Market Size by Type
  2. 11.1.1 Asia Therapeutic Nuclear Medicines Revenue by Type (2021-2032)
  3. 11.1.2 Asia Therapeutic Nuclear Medicines Sales by Type (2021-2032)
  4. 11.1.3 Asia Therapeutic Nuclear Medicines Price by Type (2021-2032)
  5. 11.2 Asia Therapeutic Nuclear Medicines Market Size by Application
  6. 11.2.1 Asia Therapeutic Nuclear Medicines Revenue by Application (2021-2032)
  7. 11.2.2 Asia Therapeutic Nuclear Medicines Sales by Application (2021-2032)
  8. 11.2.3 Asia Therapeutic Nuclear Medicines Price by Application (2021-2032)
  9. 11.3 Asia Therapeutic Nuclear Medicines Market Size by Country
  10. 11.3.1 Asia Therapeutic Nuclear Medicines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Therapeutic Nuclear Medicines Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Therapeutic Nuclear Medicines Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Therapeutic Nuclear Medicines Market Size by Type
  2. 12.1.1 SAMEA Therapeutic Nuclear Medicines Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Therapeutic Nuclear Medicines Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Therapeutic Nuclear Medicines Price by Type (2021-2032)
  5. 12.2 SAMEA Therapeutic Nuclear Medicines Market Size by Application
  6. 12.2.1 SAMEA Therapeutic Nuclear Medicines Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Therapeutic Nuclear Medicines Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Therapeutic Nuclear Medicines Price by Application (2021-2032)
  9. 12.3 SAMEA Therapeutic Nuclear Medicines Market Size by Country
  10. 12.3.1 SAMEA Therapeutic Nuclear Medicines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Therapeutic Nuclear Medicines Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Therapeutic Nuclear Medicines Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Therapeutic Nuclear Medicines Value Chain Analysis
  2. 13.1.1 Therapeutic Nuclear Medicines Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Therapeutic Nuclear Medicines Production Mode & Process
  6. 13.2 Therapeutic Nuclear Medicines Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Therapeutic Nuclear Medicines Distributors
  9. 13.2.3 Therapeutic Nuclear Medicines Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst